MarissaBWilckMD

Infectious Disease • Philadelphia, PA

Transplant/Immunocompromised States, Microbiology

Assistant Professor, Medicine, Perelman School of Medicine

Join to view full profile

Dr. Wilck is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wilck's full profile

Already have an account?

Office
3400 Spruce St.
3 Silverstein Bldg., Suite D
Philadelphia, PA 19104
Phone+1 215-662-6932

Fax+1 617-662-7899

Education & Training

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2004 - 2007
MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 2000 - 2004
Yale-New Haven Medical CenterFellowship, Medical Microbiology, 1999 - 2000
University of Cape Town Faculty of MedicineClass of 1996

Certifications & Licensure

PA State Medical License 2010 - 2024
MA State Medical License 2005 - 2010
DC State Medical License 2003 - 2004
DE State Medical License 2002 - 2003
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen ...
Alvino Maestri, Su Eun Park, Fiona Fernandes, Zhongyi Lucy Li, Yae-Jean Kim
Human Vaccines & Immunotherapeutics. 2024-12-31
A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hi...
Andrea Guerra, Claudio Costantino, Federico Martinon-Torres, Soeren Westerholt, Courtney Lambeth
Human Vaccines & Immunotherapeutics. 2024-12-31
3 citations
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vacci...
Marissa Wilck, Oliver A Cornely, Catherine Cordonnier, Juan Diego Velez, Per Ljungman
Clinical Infectious Diseases. 2023-10-13